Difference between revisions of "WSI22-117-Case-7"

From MGH Learn Pathology
(Added status template)
 
(One intermediate revision by one other user not shown)
Line 14: Line 14:
 
|performer=BQ01
 
|performer=BQ01
 
|bodySite=ENDOMETRIUM; CURETTAGE
 
|bodySite=ENDOMETRIUM; CURETTAGE
|reasonCode=Same patient as Case 6, but now has "Persistent Gestational Trophoblastic Disease" (plateau of post-evacuation beta HCG levels); offered chemo or 2nd curettage (elected the later).
+
|reasonCode=Same patient as previous case (Case 6), but now has "Persistent Gestational Trophoblastic Disease" (plateau of post-evacuation beta HCG levels); offered chemo or 2nd curettage (elected the later).
 
|supportingInfo=Retained Partial Hydatidiform Mole
 
|supportingInfo=Retained Partial Hydatidiform Mole
 
}}
 
}}
Line 26: Line 26:
 
|view=show
 
|view=show
 
|modality=ndpi
 
|modality=ndpi
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Bq01
 +
|authoredOn=August 24, 2022 07:10:58 PM
 
}}
 
}}

Latest revision as of 14:29, December 9, 2024

WSI22-117-Case-7
Same patient as previous case (Case 6), but now has "Persistent Gestational Trophoblastic Disease" (plateau of post-evacuation beta HCG levels); offered chemo or 2nd curettage (elected the later).
Retained Partial Hydatidiform Mole
August 20, 2024 12:00:00 PM